Recalls & Warnings
ConsumerLab.com is keeping you informed with current product recalls and warnings.
Posted June 30, 2013
Weight Loss Supplements Recalled Due To Undeclared Drug
Sibutramine, the active ingredient in the obesity drug Meridia, was removed from the U.S. market in October 2010 because it can substantially increase blood pressure and pulse rate in some individuals, and may present a significant risk for patients with a history of coronary artery disease, congestive heart failure, arrhythmias, or stroke. This drug may also interact, in life-threatening ways, with other medications a consumer may be taking.
The recalled lot of JaDera is marked with lot# 10.06.2011 with an expiration date of 09.06.2013. All lots of Xiyouji Qingzhi are being recalled. Both supplements were distributed nationwide from May 2011 to May 2013.
The FDA warned consumers on June 6, 2013 not to buy or use Xiyouji Qingzhi after laboratory analysis confirmed this supplement contained undeclared sibitrumine.
Consumers who have purchased these supplements should discontinue use immediately and contact their healthcare provider if they have experienced any adverse side effects. Consumers and healthcare providers are also encouraged to report any adverse reactions to the FDA's MedWatch Adverse Event Reporting Program.
See ConsumerLab.com's Review of Weight Loss Supplements for tests of related products.
See Related Warnings:
For more about this recall, use the link below.